Virum, Denmark

Henrik Vissing

This inventor holds 1 USPTO granted patent. Top assignee: Exiqon A/s. Active years: 2016.


Average Co-Inventor Count = 11.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Henrik Vissing

Introduction

Henrik Vissing is a notable inventor based in Virum, Denmark. He has made significant contributions to the field of molecular biology, particularly in the detection and analysis of nucleic acids. His work has implications for understanding various diseases, including cancer.

Latest Patents

Henrik Vissing holds a patent for "Oligonucleotides useful for detecting and analyzing nucleic acids of interest." This invention features improved nucleic acids and methods for expression profiling of mRNAs. It also includes identifying and profiling particular mRNA splice variants, as well as detecting mutations, deletions, or duplications of specific exons or other splice variants. These advancements are crucial for analyzing biological samples or patient samples, especially in the context of diseases such as cancer. He has 1 patent to his name.

Career Highlights

Henrik Vissing is associated with Exiqon A/S, a company that focuses on providing innovative solutions in the field of molecular biology. His work at Exiqon has allowed him to contribute to the development of tools that enhance the understanding of genetic information.

Collaborations

Henrik has collaborated with notable colleagues such as Peter Arctander and Niels Tolstrup. These partnerships have fostered an environment of innovation and have led to advancements in their respective fields.

Conclusion

Henrik Vissing's contributions to the field of molecular biology through his patent and work at Exiqon A/S highlight his role as an influential inventor. His innovations continue to impact the detection and analysis of nucleic acids, paving the way for advancements in medical research and diagnostics.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…